[HTML][HTML] A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

…, F Torres, A Fernández-Cruz… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …

A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality

A Fernández-Cruz, B Ruiz-Antorán… - Antimicrobial agents …, 2020 - Am Soc Microbiol
AFC and BR-A. had full access to all the data in this study and take complete responsibility
Ana Fernández-Cruz and Belén Ruiz-Antorán contributed equally to this article. First-author …

Impact of glucocorticoid treatment in SARS-CoV-2 infection mortality: a retrospective controlled cohort study

A Fernández Cruz, B Ruiz-Antoran, AM Gómez… - medRxiv, 2020 - medrxiv.org
… Writing first draft: AFC, BRA … AFC and BRA had full access to all the data in this study and
take complete responsibility for the integrity of the data and the accuracy of the data analysis. …

[HTML][HTML] Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study

…, E Sánchez-Chica, A Fernández-Cruz - Infectious diseases and …, 2021 - Springer
… Writing first draft: ASL, BRA, AFC. Critical revision for important intellectual content: all …
AFC and BRA had full access to all the data in this study and take complete responsibility for the …

[HTML][HTML] Efficacy and safety of sarilumab in patients with COVID19 pneumonia: a randomized, phase III clinical trial (SARTRE study)

…, C Avendaño-Solá, A Fernández Cruz - Infectious diseases and …, 2021 - Springer
Introduction SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-…

[HTML][HTML] Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol …

…, B Ruiz-Antorán, A Fernández Cruz… - Trials, 2020 - Springer
Objectives In some patients, acute, life-threatening respiratory injury produced by viruses such
as SARS-CoV and other viral pneumonia are associated with an over-exuberant cytokine …

Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years

A Fernández-Cruz, P Muñoz, R Mohedano, M Valerio… - Medicine, 2010 - journals.lww.com
Campylobacter is a very rare cause of bloodstream infection, although it has been found
relatively frequently in patients infected with human immunodeficiency virus (HIV). The impact of …

[HTML][HTML] Red blood cell distribution width as prognostic factor in sepsis: A new use for a classical parameter

…, J Calderón-Parra, A Fernandez-Cruz… - Journal of Critical …, 2022 - Elsevier
Purpose To evaluate Red blood cell distribution width (RDW) as a sepsis prognostic biomarker.
Methods 203 septic patients admitted to the ICU. Analysis of RDW dynamics, hospital …

COVID‐19‐associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID‐19 patients

…, A Ramos‐Martinez, A FernándezCruz… - Mycoses, 2022 - Wiley Online Library
Ana Fernández-CruzAFC declares personal fees for lectures/presentations/educational
events outside the present manuscript. All other authors declare no conflicts of interest. …

[HTML][HTML] Red blood cell distribution width as a marker of hyperinflammation and mortality in COVID-19

…, B Ruiz-Antoran, A Fernandez-Cruz - Annals of Palliative …, 2022 - apm.amegroups.org
Background: Red blood cell distribution width (RDW) could reflect interleukin-6 (IL-6)
systemic activity since anisocytosis represents the inhibition of erythropoiesis, leaded by the …